Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MATTHEW A BERGER

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1295718237
CMS profile
12737
Location
MOOSIC, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$318,013.17

396 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 4 of 8; records 151–200 of 396 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MATTHEW A BERGER

NPI 1295718237 · CMS profile ID 12737

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry

MOOSIC, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 8; records 151–200 of 396 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1295718237?year=2025&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MATTHEW A BERGER, NPI 1295718237, CMS profile ID 12737. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 8; records 151–200 of 396 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1295718237?year=2025&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). MATTHEW A BERGER, NPI 1295718237, CMS profile ID 12737. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 8; records 151–200 of 396 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1295718237?year=2025&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
MATTHEW A BERGER, NPI 1295718237, CMS profile ID 12737, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 8; records 151–200 of 396 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1295718237?year=2025&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

396 matching records · $318,013.17 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 396 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–200 of 396.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Neurocrine BioSciences, Inc. $25.9008/08/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1243002062 CMS
Neurocrine BioSciences, Inc. $14.4308/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1243044358 CMS
ABBVIE INC. $9.6108/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201504324 CMS
E.R. Squibb & Sons, L.L.C. $2,300.0008/05/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1184840859 CMS
Biogen, Inc. $14.6508/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208371009 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.5208/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241256229 CMS
Corium, LLC $16.1008/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1185799814 CMS
Vanda Pharmaceuticals Inc. $41.0808/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232949064 CMS
Vanda Pharmaceuticals Inc. $2,100.0008/01/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1232949066 CMS
Vanda Pharmaceuticals Inc. $18.9008/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1232949068 CMS
Almatica Pharma LLC $18.1007/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1209929892 CMS
Otsuka America Pharmaceutical, Inc. $2,548.0007/30/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1227294497 CMS
Otsuka America Pharmaceutical, Inc. $1.4007/30/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1227294499 CMS
Otsuka America Pharmaceutical, Inc. $51.1007/30/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1227294501 CMS
Otsuka America Pharmaceutical, Inc. $422.4007/29/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1227294493 CMS
Otsuka America Pharmaceutical, Inc. $422.4007/29/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1227294495 CMS
Neurocrine BioSciences, Inc. $10.4607/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1243049281 CMS
Otsuka America Pharmaceutical, Inc. $2,548.0007/25/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1227294491 CMS
E.R. Squibb & Sons, L.L.C. $122.2907/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184840855 CMS
Otsuka America Pharmaceutical, Inc. $21.4207/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227294485 CMS
Otsuka America Pharmaceutical, Inc. $2,548.0007/23/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1227294487 CMS
Otsuka America Pharmaceutical, Inc. $75.0007/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227294489 CMS
Janssen Pharmaceuticals, Inc $12.6207/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174826011 CMS
Teva Pharmaceuticals USA, Inc. $10.6807/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247306575 CMS
Otsuka America Pharmaceutical, Inc. $15.4207/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227294483 CMS
Axsome Therapeutics, Inc. $1,100.0007/17/2025 Honoraria No dispute reported Delay: No
Change: NEW
06/30/2026 1235750838 CMS
Almatica Pharma LLC $17.0207/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1209929890 CMS
Teva Pharmaceuticals USA, Inc. $112.7007/15/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1247306563 CMS
Teva Pharmaceuticals USA, Inc. $4,226.0007/15/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1247306565 CMS
Janssen Pharmaceuticals, Inc $585.0007/11/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1174824271 CMS
Neurocrine BioSciences, Inc. $2,300.0007/10/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1242957163 CMS
Otsuka America Pharmaceutical, Inc. $9.7307/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227294481 CMS
ABBVIE INC. $11.7207/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201504322 CMS
Neurocrine BioSciences, Inc. $9.3307/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1243050423 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1.8007/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241256227 CMS
Axsome Therapeutics, Inc. $2,750.0006/30/2025 Honoraria No dispute reported Delay: No
Change: NEW
06/30/2026 1235756005 CMS
ABBVIE INC. $6.9806/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201504320 CMS
Otsuka America Pharmaceutical, Inc. $49.0006/27/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1227294479 CMS
Teva Pharmaceuticals USA, Inc. $11.9706/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247306557 CMS
Otsuka America Pharmaceutical, Inc. $2,548.0006/25/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1227294475 CMS
Otsuka America Pharmaceutical, Inc. $877.5006/25/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1227294477 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.2906/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241256223 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $11.3606/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241256225 CMS
Otsuka America Pharmaceutical, Inc. $1,513.6006/23/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1227294471 CMS
Otsuka America Pharmaceutical, Inc. $3,724.0006/23/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1227294473 CMS
ABBVIE INC. $16.9706/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201504318 CMS
Biogen, Inc. $19.9106/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208350787 CMS
Otsuka America Pharmaceutical, Inc. $22.7206/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227294467 CMS
Otsuka America Pharmaceutical, Inc. $122.3406/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227294469 CMS
Neurocrine BioSciences, Inc. $7.0906/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1243052831 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $186,586.48 358
PY2020 $87,068.72 218
PY2021 $161,102.28 318
PY2022 $220,898.75 334
PY2023 $352,175.73 448
PY2024 $354,059.61 414
PY2025 $318,013.17 396

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $45,843.80 56
PY2024 Principal investigator $44,291.95 62
PY2023 Principal investigator $147,061.19 36
PY2022 Principal investigator $319,162.45 63
PY2021 Principal investigator $140,862.99 45
PY2020 Principal investigator $16,600.00 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

56 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 LivaNova USA, Inc. $1,246.20 11/11/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549466
Principal investigator 1 LivaNova USA, Inc. $1,246.20 11/11/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549481
Principal investigator 1 LivaNova USA, Inc. $1,246.20 09/09/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549347
Principal investigator 1 LivaNova USA, Inc. $1,165.80 08/09/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549331
Principal investigator 1 LivaNova USA, Inc. $1,246.20 08/09/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549336
Principal investigator 1 LivaNova USA, Inc. $100.50 08/09/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549340
Principal investigator 1 LivaNova USA, Inc. $308.20 08/09/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549344
Principal investigator 1 LivaNova USA, Inc. $1,246.20 08/09/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549377
Principal investigator 1 LivaNova USA, Inc. $1,246.20 08/09/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549381
Principal investigator 1 LivaNova USA, Inc. $1,246.20 08/09/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549385
Principal investigator 1 LivaNova USA, Inc. $1,246.20 08/09/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549388
Principal investigator 1 LivaNova USA, Inc. $1,246.20 08/09/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549392
Principal investigator 1 LivaNova USA, Inc. $100.50 08/09/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549396
Principal investigator 1 LivaNova USA, Inc. $308.20 08/09/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549400
Principal investigator 1 LivaNova USA, Inc. $1,345.00 08/07/2025 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1245556969
Principal investigator 1 LivaNova USA, Inc. $90.00 06/17/2025 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1245556772
Principal investigator 1 LivaNova USA, Inc. $1,246.20 06/10/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549262
Principal investigator 1 LivaNova USA, Inc. $100.50 06/10/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549267
Principal investigator 1 LivaNova USA, Inc. $1,246.20 06/10/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549285
Principal investigator 1 LivaNova USA, Inc. $1,165.80 05/09/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549251
Principal investigator 1 LivaNova USA, Inc. $1,246.20 05/09/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549255
Principal investigator 1 LivaNova USA, Inc. $100.50 05/09/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549258
Principal investigator 1 LivaNova USA, Inc. $1,165.80 05/09/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549288
Principal investigator 1 LivaNova USA, Inc. $100.50 05/09/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549292
Principal investigator 1 LivaNova USA, Inc. $1,165.80 04/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549233
Principal investigator 1 LivaNova USA, Inc. $1,246.20 04/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549237
Principal investigator 1 LivaNova USA, Inc. $100.50 04/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549242
Principal investigator 1 LivaNova USA, Inc. $308.20 04/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549246
Principal investigator 1 LivaNova USA, Inc. $100.50 04/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549296
Principal investigator 1 LivaNova USA, Inc. $100.50 04/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549301
Principal investigator 1 LivaNova USA, Inc. $1,246.20 04/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549305
Principal investigator 1 LivaNova USA, Inc. $1,165.80 04/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549309
Principal investigator 1 Otsuka Pharmaceutical Development & Commercialization, Inc. $2,300.00 03/21/2025 Non-covered Recipient Entity
GLOBAL MEDICAL INSTITUTES LLC
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF AVP-786 (DEUDEXTROMETHORPHAN HYDROBROMIDE [D6-DM]/QUINIDINE SULFATE [Q]) FOR THE TREATMENT OF AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMERS TYPE No dispute reported 06/30/2026 1225335731
Principal investigator 1 LivaNova USA, Inc. $1,246.20 03/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549208
Principal investigator 1 LivaNova USA, Inc. $100.50 03/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549212
Principal investigator 1 LivaNova USA, Inc. $100.50 03/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549314
Principal investigator 1 LivaNova USA, Inc. $1,246.20 03/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549323
Principal investigator 1 LivaNova USA, Inc. $1,246.20 03/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549327
Principal investigator 1 LivaNova USA, Inc. $1,246.20 03/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549477
Principal investigator 1 LivaNova USA, Inc. $380.00 02/11/2025 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1245556554
Principal investigator 1 LivaNova USA, Inc. $380.00 02/11/2025 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1245556620
Principal investigator 1 LivaNova USA, Inc. $1,246.20 02/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549126
Principal investigator 1 LivaNova USA, Inc. $1,165.80 02/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549130
Principal investigator 1 LivaNova USA, Inc. $100.50 02/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549134
Principal investigator 1 LivaNova USA, Inc. $100.50 02/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549158
Principal investigator 1 LivaNova USA, Inc. $1,165.80 02/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549161
Principal investigator 1 LivaNova USA, Inc. $1,246.20 01/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549110
Principal investigator 1 LivaNova USA, Inc. $1,165.80 01/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549114
Principal investigator 1 LivaNova USA, Inc. $100.50 01/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549118
Principal investigator 1 LivaNova USA, Inc. $308.20 01/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549122
Principal investigator 1 LivaNova USA, Inc. $100.50 01/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549165
Principal investigator 1 LivaNova USA, Inc. $1,246.20 01/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549168
Principal investigator 1 LivaNova USA, Inc. $1,246.20 01/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549171
Principal investigator 1 LivaNova USA, Inc. $1,246.20 01/08/2025 Non-covered Recipient Entity
Global Medical Institutes, LLC
RECOVER No dispute reported 06/30/2026 1245549174
Principal investigator 1 LivaNova USA, Inc. $360.00 01/07/2025 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1245556562
Principal investigator 1 LivaNova USA, Inc. $360.00 01/07/2025 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1245557070